256 Newsroom — Uganda's Digital News Infrastructure
Health

A German biotech has big ambitions in cancer. Now it needs to get a medicine approved - STAT

Published by STAT By Andrew Joseph · 21 October 2026 at 11:33
Share
A German biotech has big ambitions in cancer. Now it needs to get a medicine approved - STAT
Image · STAT

What the report says

After a quarter century of work, the German biotech Immatics is facing a pivotal moment as it awaits Phase 3 results for its lead candidate in melanoma.

Read the full report at STAT →

Loading debate for this article…

Other publishers covering this story

No additional verified coverage is currently clustered with this report.

More stories by this journalist

Other publications from this journalist — open any story without leaving the article page.

No other published stories from this publisher yet.

Related reporting

Lango Seeks Japanese Investment in Agriculture, Industry and Social ServicesNile Post Medicine shortages undermining village health teamsThe Observer Depression: Walking Through the Three Corners of Life Toward HealingNile Post Ebola: Uganda Reinstates Traveller Locator FormsNile Post 256 Newsroom Uganda remains Ebola-free as Health ministry probes Nigerian traveller infected with virus - Daily MonitorDaily Monitor Atwine Warns Border Officers Over Ebola Screening Lapses at MpondweNile Post